REPLY
Recommendations for Reporting Clinical Trials
Susan Eastwood, ELS(D)
1 March 1997 | Volume 126 Issue 5 | Page 411
IN RESPONSE:
As correspondent for the Asilomar Working Group on Recommendations for Reporting of Clinical Trials in the Biomedical Literature, I would like to relay our appreciation of Dr. Marciniak's suggested additions to our checklist.
|
Author and Article Information
|
|---|
 Top
 Author & Article Info
|
|---|
University of California, San Francisco, San Francisco, CA 94143
About Letters
The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:
•Include no more than 300 words of text, three authors, and five references
•Type with double-spacing
•Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.
Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified that the letter has been received. If the letter is selected for publication, the author will be notified about 3 weeks before the publication date. Unpublished letters cannot be returned.
Annals welcomes electronically submitted letters.
Article
